Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2019 Apr 17:17:e00539.
doi: 10.1016/j.idcr.2019.e00539. eCollection 2019.

Oxacillin-induced leukocytoclastic vasculitis

Affiliations
Case Reports

Oxacillin-induced leukocytoclastic vasculitis

Meric Mericliler et al. IDCases. .

Abstract

Leukocytoclastic vasculitis (LCV) refers to a histopathological pattern of neutrophil predominant inflammatory process of small vessels associated with fibrinoid necrosis. Cutaneous LCV usually presents as symmetrically distributed palpable purpuric nodules of the lower extremities with or without systemic involvement. Although 50% of LCV cases are idiopathic, it can be secondary to identifiable causes such as malignancy, autoimmune conditions, infections, and medications. Medications have been implicated in up to 25% of cases; sulfonamides, NSAIDs, and beta-lactams have the most frequent association. We herein present a 32-year-old female who developed palpable purpura over hands and lower limbs 12 days after exposure to oxacillin administered for infective endocarditis. Punch biopsy from the skin lesions confirmed the diagnosis of LCV. Given the temporal relationship between oxacillin administration and development of skin findings, the diagnosis of oxacillin-associated LCV was suspected. Discontinuation of drug resulted in resolution of the lesions confirming the diagnosis. To our knowledge, this is the second case of oxacillin-induced cutaneous LCV described in literature.

Keywords: Adverse event; Antimicrobial; Immune-mediated; Leukocytoclastic; Oxacillin; Small-vessel; Vasculitis.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Palpable purpuric and bullous lesions localized predominantly on the dorsal aspect of hands (A) and feet (B).
Fig. 2
Fig. 2
Multiple palpable round-ovular lesions cover the lateral (A) and anterior (B) aspect of the lower limbs.
Fig. 3
Fig. 3
Histopathological section demonstrating patchy perivascular neutrophil predominant infiltrate with areas of fibrinoid necrosis of blood vessels, nuclear debris and hemorrhage (H and E, 10x and 40x, respectively) in the dermis.

References

    1. Baigrie D., Crane J.S. StatPearls Publishing; StatPearls, Treasure Island (FL): 2018. Leukocytoclastic vasculitis (Hypersensitivity vasculitis) - PubMed
    1. Goeser M.R., Laniosz V., Wetter D.A. A practical approach to the diagnosis, evaluation, and management of cutaneous small-vessel vasculitis. Am J Clin Dermatol. 2014;15(4):299–306. - PubMed
    1. Chen S.X., Cohen P.R. Cutaneous leukocytoclastic vasculitis following influenza vaccination in older adults: report of bullous purpura in an octogenarian after influenza vaccine administration. Cureus. 2018;10(3) - PMC - PubMed
    1. Crowson A.N., Mihm M.C., Magro C.M. Cutaneous vasculitis: a review. J Cutan Pathol. 2003;30(3):161–173. - PubMed
    1. García-Porrúa C., González-Gay M.A., López-Lázaro L. Drug associated cutaneous vasculitis in adults in northwestern Spain. J Rheumatol. 1999;26(9):1942–1944. - PubMed

Publication types

LinkOut - more resources